| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 29 | +31.03% | +4.54% | +1.04% | +3.50% | +3.22% | — |
| 14d | 29 | +31.03% | +5.19% | +0.88% | +4.32% | +4.83% | — |
| 30d | 29 | +17.24% | +16.75% | +2.59% | +14.16% | +13.82% | — |
| 60d | 29 | +13.79% | +28.35% | +5.57% | +22.78% | +30.90% | — |
| 90d | 29 | +31.03% | +31.45% | +7.64% | +23.81% | +29.20% | — |
| 180d | 29 | +37.93% | +17.08% | +14.60% | +2.48% | +1.06% | — |
| 1y | 29(4 pending) | +80.00% | -21.35% | +29.35% | -50.70% | -59.73% | — |
| 2y | 29(5 pending) | +87.50% | -35.78% | +26.06% | -61.84% | -65.80% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 10,800 | $7.20 | $77.7K | 59,750 | Jun 12, 2026 | Jun 15, 2026 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 70,550 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 6,103 | — | — | 0 | Mar 23, 2026 | Mar 25, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 6,103 | $6.15 | $37.5K | 435,456 | Mar 23, 2026 | Mar 25, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 13,489 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 15,000 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 10,034 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 13,711 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 65,091 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 1,120,000 | — | — | 1,120,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 182,500 | — | — | 429,353 | Nov 13, 2025 | Nov 14, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 36,615 | $8.94 | $327.4K | 246,853 | Sep 29, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 182,500 | — | — | 283,468 | Sep 27, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President & CEO | 50,000 | $8.20 | $410.1K | 100,968 | Sep 8, 2025 | Sep 9, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $50.00 | $750.0K | 54,425 | Sep 5, 2025 | Sep 9, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 14,500 | $12.48 | $181.0K | 83,925 | Sep 5, 2025 | Sep 9, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 14,500 | $50.00 | $725.0K | 69,425 | Sep 5, 2025 | Sep 9, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 14,500 | — | — | 0 | Sep 5, 2025 | Sep 9, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 13,494 | $6.64 | $89.6K | 50,968 | Aug 13, 2025 | Aug 13, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 36,506 | $5.85 | $213.6K | 37,474 | Aug 12, 2025 | Aug 13, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $45.00 | $675.0K | 285,000 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 17,777 | $45.00 | $800.0K | 17,776 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 7,500 | $12.48 | $93.6K | 76,925 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,500 | $45.00 | $337.5K | 69,425 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 22,000 | $12.03 | $264.7K | 91,425 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 22,000 | $45.00 | $990.0K | 69,425 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 22,000 | — | — | 0 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 7,500 | — | — | 14,500 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 10,800 | $3.40 | $36.7K | 43,550 | Jun 13, 2025 | Jun 17, 2025 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 54,350 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,692 | — | — | 69,425 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,034 | — | — | 10,034 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 625,000 | — | — | 625,000 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,350 | Jun 18, 2024 | Jun 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,489 | — | — | 13,489 | Jun 13, 2024 | Jun 14, 2024 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 27,000 | $3.33 | $89.9K | 350 | Jun 13, 2024 | Jun 17, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 84,107 | $6.15 | $517.3K | 84,666 | Jan 24, 2024 | Jan 26, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 6,945 | $4.80 | $33.3K | 7,504 | Jan 24, 2024 | Jan 26, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 6,945 | $20.23 | $140.5K | 559 | Jan 24, 2024 | Jan 26, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 84,107 | $20.23 | $1.70M | 559 | Jan 24, 2024 | Jan 26, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 560,000 | — | — | 560,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 250,000 | — | — | 300,000 | Dec 12, 2023 | Dec 14, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 250,000 | — | — | 13,711 | Dec 12, 2023 | Dec 14, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 300,000 | — | — | 300,000 | Dec 12, 2023 | Dec 14, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 300,000 | — | — | 263,711 | Dec 12, 2023 | Dec 14, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALEGRANT Gift | 2,000 | — | — | 559 | Dec 7, 2023 | Dec 11, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALEGRANT Gift | 1,000 | — | — | 279,194 | Dec 7, 2023 | Dec 11, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,000 | — | — | 22,000 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,350 | Jun 13, 2023 | Jun 15, 2023 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 27,000 | $3.45 | $93.3K | 350 | Jun 13, 2023 | Jun 15, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 300,000 | — | — | 280,194 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 300,000 | — | — | 580,194 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 300,000 | — | — | 300,000 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 27,966 | — | — | 2,559 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 8,394 | — | — | 1,134,012 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 212,500 | — | — | 880,194 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 41,318 | — | — | 1,092,694 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 8,394 | — | — | 0 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 560,000 | — | — | 560,000 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 1,084,300 | — | — | 1,125,618 | Oct 6, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 1,084,300 | — | — | 8,394 | Oct 6, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 41,318 | — | — | 1,092,694 | Aug 19, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 17,708 | — | — | 1,134,012 | Aug 19, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 11,985 | — | — | 30,525 | Aug 19, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 41,318 | — | — | 41,318 | Aug 19, 2022 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 468,297 | — | — | 1,151,720 | Jul 14, 2022 | Feb 21, 2023 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE | 27,858 | $2.58 | $72.0K | 27,350 | Jun 16, 2022 | Jun 21, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,000 | — | — | 22,000 | Jun 15, 2022 | Jun 17, 2022 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 55,208 | Jun 14, 2022 | Jun 16, 2022 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 495,000 | — | — | 495,000 | Jan 26, 2022 | Jan 28, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jun 16, 2021 | Jun 16, 2021 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 27,858 | — | — | 28,208 | Jun 15, 2021 | Jun 17, 2021 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE | 25,748 | $11.36 | $292.4K | 350 | Jun 10, 2021 | Jun 11, 2021 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 366,500 | — | — | 366,500 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 175,000 | — | — | 1,620,017 | Dec 23, 2020 | Jan 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 100,000 | — | — | 89,618 | Dec 22, 2020 | Dec 28, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 100,000 | — | — | 100,000 | Dec 22, 2020 | Dec 28, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 11,855 | — | — | 90,210 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 11,855 | $6.15 | $72.9K | 39,951 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 50,370 | — | — | 102,065 | Oct 8, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 50,370 | $6.15 | $309.8K | 78,466 | Oct 8, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 106,736 | $34.00 | $3.63M | 0 | Oct 8, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 50,370 | $34.00 | $1.71M | 28,096 | Oct 8, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 4,586 | $34.00 | $155.9K | 28,096 | Oct 7, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 99,900 | $32.00 | $3.20M | 106,736 | Oct 7, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 4,586 | $6.15 | $28.2K | 32,682 | Oct 7, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 4,586 | — | — | 152,435 | Oct 7, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 100 | $32.00 | $3.2K | 206,636 | Oct 6, 2020 | Oct 8, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 98,490 | $28.82 | $2.84M | 206,736 | Sep 14, 2020 | Sep 15, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 17,926 | $28.00 | $501.9K | 28,096 | Sep 11, 2020 | Sep 15, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 485 | $28.00 | $13.6K | 305,226 | Sep 11, 2020 | Sep 15, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 17,926 | — | — | 157,021 | Sep 11, 2020 | Sep 15, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 17,926 | $6.15 | $110.2K | 46,022 | Sep 11, 2020 | Sep 15, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 1,025 | $28.00 | $28.7K | 305,711 | Sep 10, 2020 | Sep 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 37,030 | — | — | 174,947 | Sep 10, 2020 | Sep 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 37,030 | $28.00 | $1.04M | 28,096 | Sep 10, 2020 | Sep 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 37,030 | $6.15 | $227.7K | 65,126 | Sep 10, 2020 | Sep 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 50,000 | $26.00 | $1.30M | 306,736 | Sep 8, 2020 | Sep 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 22,838 | $6.15 | $140.5K | 50,934 | Aug 25, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 215 | $4.80 | $1.0K | 51,149 | Aug 25, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 22,838 | — | — | 211,977 | Aug 25, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 23,053 | $22.37 | $515.8K | 28,096 | Aug 25, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 215 | — | — | 6,945 | Aug 25, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 6,568 | — | — | 7,160 | Aug 24, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 6,568 | $4.80 | $31.5K | 34,664 | Aug 24, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 6,568 | $22.04 | $144.8K | 28,096 | Aug 24, 2020 | Aug 26, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 11,913 | — | — | 13,728 | Aug 19, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 11,913 | $22.09 | $263.2K | 28,096 | Aug 19, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 11,913 | $4.80 | $57.2K | 40,009 | Aug 19, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 521 | $4.80 | $2.5K | 28,617 | Aug 18, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 521 | — | — | 25,641 | Aug 18, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 521 | $22.00 | $11.5K | 28,096 | Aug 18, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 12,901 | — | — | 26,162 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 12,901 | $22.00 | $283.9K | 28,096 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 50,000 | $22.00 | $1.10M | 356,736 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Gift | 26,041 | — | — | 1,795,017 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 12,901 | $4.80 | $61.9K | 40,997 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALEGRANT Gift | 26,041 | — | — | 28,096 | Aug 17, 2020 | Aug 19, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 108,504 | — | — | 0 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 254,907 | — | — | 0 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 189,042 | — | — | 805,301 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 35,374 | — | — | 0 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | SALE | 25,245 | $9.97 | $251.7K | 26,098 | Jun 11, 2020 | Jun 12, 2020 ↗ | View → |
| PBYI PUMA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 25,748 | — | — | 51,343 | Jun 9, 2020 | Jun 10, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 1,185 | — | — | 234,815 | Feb 11, 2020 | Feb 12, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 26,911 | $4.80 | $129.2K | 54,137 | Feb 11, 2020 | Feb 12, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASE President and CEO | 1,185 | $6.15 | $7.3K | 27,226 | Feb 11, 2020 | Feb 12, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE President and CEO | 26,911 | — | — | 39,063 | Feb 11, 2020 | Feb 12, 2020 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 393,950 | — | — | 393,950 | Jan 30, 2020 | Feb 3, 2020 ↗ | View → |